Bordeaux

• MInimal residual Disease Adapted Strategy / IFM 2020-02 Pending
  2024-513889-19-00 5 Multiple Myeloma
• A Phase 1 Study of BMS-986460 in Metastatic Castration-resistant Prostate Cancer Pending
  2024-513987-24-00 1 Metastatic Castration-resistant Prostate Cancer
• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy … Pending
  2024-514388-24-00 4 Knee osteoarthritis
• Randomized double blind controlled trial comparing the safety and efficacy of apremilast versus placebo in severe forms of recurrent aphthou … Pending
  2024-514659-13-00 5 Patients with severe forms of Recurrent Aphthous Stomatitis (RAS)
• BOOSTERS - BiOlogics in FOlliculitis decalvanS : an adaptaTivE tRial reSearch Pending
  2024-514848-88-00 4 Folliculitis decalvans
• ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi … Pending
  2024-515107-19-00 5 Patients (male or female) ≥18 years old with Detrusor overactivity (DO
• SHort course of Amoxicilline for eRysipElas II Pending
  2024-515306-61-00 6 Adults diagnosed with lower limbs erysipelas
• Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer Pending
  2024-515339-30-00 4 Ovarian Cancer
• Efficacy of prophylactic levetiracetam for improving functional outcome in the acute phase of intracerebral haemorrhage: a randomised, doub … Pending
  2024-515663-59-00 5 intracerebral haemorrhage
• Stop Treatment in gout Pending
  2024-515714-40-00 4 Gout adult patients
• Severe Erythema Multiforme - CORTICO Pending
  2024-516018-39-00 5 Erythema multiforme (EM) in its severe form managed at the hospital
• BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending
  2024-516849-39-01 5 antibiotic therapy in Sepsis
• ALADDIN: evaluation of dAroLutamide Addition to anDrogen Deprivation therapy and radIatioN therapy in newly diagnosed prostate cancer with p … Pending
  2024-517285-41-00 5 Newly diagnosed prostate cancer with pelvic lymph nodes metastases
• A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02 … Pending
  2024-517339-30-00 7 Advanced Solid Tumors
• A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient … Pending
  2024-517621-54-00 5 High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
• A phase IIb, randomized, double-blind, multicenter study evaluating the efficacy of botulinum toxin versus placebo on pain and health relate … Pending
  2024-517948-66-00 4 Piriformis muscle syndrome
• Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct … Pending
  2024-518139-12-00 4 locally advanced or metastatic Pancreatic ductal adenocarcinoma
• Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma pat … Pending
  2024-518199-30-00 9 Soft tissue sarcoma patients
• Regenerative Stem Cell Therapy for Stroke in Europe 1 Pending
  2024-518394-34-00 1 stroke
• Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease Pending
  2024-518437-28-00 5 Sickle cell disease
• Efficacy and safety of allogenic cultured Adipose-derived mesenchymal stromal cell injections on MoUth fibrosis and handicap in patients wit … Pending
  2024-518516-39-00 4 Systemic sclEroderma
• REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending
  2024-519298-21-00 5 Cancer-Associated Thrombosis (CAT).
• Efficacy of non operative treatment with amoxicillin/clavulanic acid versus surgical treatment in acute uncomplicated appendicitis in childr … Pending
  2024-519402-12-00 5 uncomplicated appendicitis
• Tucatinib and trastuzumab in HER3-mutant and HER2-not amplified metastatic breast cancer Pending
  2024-519624-24-00 4 HER3-mutant and HER2-not amplified metastatic breast cancer

Showing 25–48 of 1,109 trials